These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity. Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588 [TBL] [Abstract][Full Text] [Related]
3. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice. Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097 [TBL] [Abstract][Full Text] [Related]
4. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells. Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235 [TBL] [Abstract][Full Text] [Related]
5. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898 [TBL] [Abstract][Full Text] [Related]
6. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Wiley DT; Webster P; Gale A; Davis ME Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374 [TBL] [Abstract][Full Text] [Related]
7. Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis. Yang YR; Xiong XY; Liu J; Wu LR; Zhong Q; Zhou K; Meng ZY; Liu L; Wang FX; Gong QW; Liao MF; Duan CM; Li J; Yang MH; Zhang Q; Gong CX; Yang QW J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724654 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo methods for assessing FcRn-mediated reverse transcytosis across the blood-brain barrier. Caram-Salas N; Boileau E; Farrington GK; Garber E; Brunette E; Abulrob A; Stanimirovic D Methods Mol Biol; 2011; 763():383-401. PubMed ID: 21874466 [TBL] [Abstract][Full Text] [Related]
15. Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier. Holst MR; de Wit NM; Ozgür B; Brachner A; Hyldig K; Appelt-Menzel A; Sleven H; Cader Z; de Vries HE; Neuhaus W; Jensen A; Brodin B; Nielsen MS Fluids Barriers CNS; 2023 Nov; 20(1):82. PubMed ID: 37932749 [TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies. Zuchero YJ; Chen X; Bien-Ly N; Bumbaca D; Tong RK; Gao X; Zhang S; Hoyte K; Luk W; Huntley MA; Phu L; Tan C; Kallop D; Weimer RM; Lu Y; Kirkpatrick DS; Ernst JA; Chih B; Dennis MS; Watts RJ Neuron; 2016 Jan; 89(1):70-82. PubMed ID: 26687840 [TBL] [Abstract][Full Text] [Related]
17. Intracellular transport and regulation of transcytosis across the blood-brain barrier. Villaseñor R; Lampe J; Schwaninger M; Collin L Cell Mol Life Sci; 2019 Mar; 76(6):1081-1092. PubMed ID: 30523362 [TBL] [Abstract][Full Text] [Related]